# A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039)

> **NCT07121959** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Metformin
- **DRUG:** Belzutifan

## Key facts

- **NCT ID:** NCT07121959
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-18
- **Primary completion:** 2025-09-13
- **Final completion:** 2025-09-26
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07121959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07121959, "A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07121959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*